U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517432) titled 'The UGIRA International Registry for RAMIG for Gastric Cancer' on March 23.
Brief Summary: Minimally invasive gastrectomy (MIG) has gained in popularity, since it is feasible, safe and oncologically comparable to open gastrectomy, while morbidity and duration of hospitalization are reduced, quality of life is increased, and conversion rate is low.
However, several challenges are faced during MIG, such as impaired depth perception and limited range of motion of instrument tips. Robot-Assisted Minimally Invasive Gastrectomy (RAMIG) can potentially overcome these challenges, while providing comparable results regarding safety, technic...